-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On April 16, Frontage Pharmaceuticals announced the acquisition of Ocean Ridge Biosciences in the United States
.
Ocean Ridge Biosciences is located in Deerfield Beach, Florida, and provides genomics services for customers developing new therapies, including complete service solutions for analyzing RNA expression, DNA polymorphism, methylation, microbial composition, and protein biomarkers in a wide range of samples
.
The company's wet laboratory services can meet ultra-low investment requirements and challenging sample types (such as formalin-fixed paraffin-embedded tissue, skin swabs, and various biological fluids), and are also used in mechanisms such as mechanism of action and lead optimization , Biomarker discovery and development of companion diagnostics and other core application areas
"Ocean Ridge Biosciences has been established for more than 15 years.
It is a next-generation sequencing (NGS) service that uses RNA, mRNA and microRNA arrays as a pioneer in the detection and treatment of disease biomarkers
.
" Executive Vice President, Global Bioanalysis Services, Fangda Pharmaceuticals Dr.
David Willoughby, founder and senior scientist of Ocean Ridge Bioscience, said: “We are very pleased to join the Frontage Pharmaceuticals team to bring a series of unique genomics services developed by Ocean Ridge, which will be provided to customers in the U.
S.
and global industries for a wider range of applications.
Treatment projects.
Ocean Ridge Bioscience will effectively complement Frontage’s current extensive IND and clinical support services, including protein, oligonucleotide, gene and cell therapy R&D services
.
"
